Provided by Tiger Trade Technology Pte. Ltd.

Black Diamond Therapeutics, Inc.

2.13
-0.0800-3.62%
Volume:73.36K
Turnover:158.60K
Market Cap:122.03M
PE:-2.86
High:2.22
Open:2.22
Low:2.13
Close:2.21
52wk High:4.94
52wk Low:1.60
Shares:57.29M
Float Shares:50.87M
Volume Ratio:1.14
T/O Rate:0.14%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7446
EPS(LYR):0.3900
ROE:-37.21%
ROA:-19.11%
PB:1.27
PE(LYR):5.46

Loading ...

Black Diamond Therapeutics Inc expected to post a loss of 19 cents a share - Earnings Preview

Reuters
·
May 09

Black Diamond Therapeutics: Q1 EPS $-0.16

THOMSON REUTERS
·
May 07

Black Diamond Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update

GlobeNewswire
·
May 07

Black Diamond Therapeutics Q1 FY26 net loss widens to $9.04 million; no revenue

Reuters
·
May 07

Olema appoints Prakash Raman to board of directors

Reuters
·
Apr 30

Black Diamond presents Phase 2 silevertinib data in frontline EGFR-mutant NSCLC at ASCO

Reuters
·
Apr 21

Black Diamond Therapeutics (BDTX) Profit Swing To US$0.81 EPS Challenges Bearish Earnings Narratives

Simply Wall St.
·
Mar 18

Stifel Nicolaus Keeps Their Buy Rating on Black Diamond Therapeutics (BDTX)

TIPRANKS
·
Mar 17

Wedbush Lifts Price Target on Black Diamond Therapeutics to $14 From $13, Keeps Outperform Rating

MT Newswires Live
·
Mar 17

Black Diamond Therapeutics (BDTX) Receives a Buy from TD Cowen

TIPRANKS
·
Mar 17

Black Diamond Therapeutics reports Q4 EPS (27c), consensus (17c)

TIPRANKS
·
Mar 17

Black Diamond Therapeutics Q4 net loss narrows 5.43% to USD 15.12 million

Reuters
·
Mar 17

Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

THOMSON REUTERS
·
Mar 17

Black Diamond Therapeutics Q4 Income From Operations USD -17.61 Million

THOMSON REUTERS
·
Mar 17

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Mar 16

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Mar 13

Black Diamond Therapeutics to Present at TD Cowen Healthcare Conference

Reuters
·
Mar 03

Black Diamond Therapeutics Inc expected to post a loss of 19 cents a share - Earnings Preview

Reuters
·
Mar 02